The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Recent Advances in Ligand-Based Drug Design: Relevance and Utility of the Conformationally Sampled Pharmacophore Approach
Open accessAbstract
In the absence of three-dimensional (3D) structures of potential drug targets, ligand-based drug design is one of the popular approaches for drug discovery and lead optimization. 3D structure-activity relationships (3D QSAR) and pharmacophore modeling are the most important and widely used tools in ligand-based drug design that can provide crucial insights into the nature of the interactions between drug target and ligand molecule and provide predictive models suitable for lead compound optimization. This review article will briefly discuss the features and potential application of recent advances in ligand-based drug design, with emphasis on a detailed description of a novel 3D QSAR method based on the conformationally sample pharmacophore (CSP) approach (denoted CSP-SAR). In addition, data from a published study are used to compare the CSP-SAR approach to the Catalyst method, emphasizing the utility of the CSP approach for ligand-based model development. Keywords: CoMFA, computer-aided drug design, CoMSIA, CSP, drug discovery, lead optimization, pharmacophore, Ligand-Based Drug Design, silico chemical alteration, conformationally-sampled pharmacophore (CSP), SAR method, molecular mechanics, quantum mechanical methods, Multivariable linear regression analysis (MLR), Principal component analysis (PCA), Partial least square analysis (PLS), MATLAB, Bayesian regularized artificial neural network (BRANN), internal validation, external validation, k-fold cross, Hansch/Free- Wilson method, CATALYST, Hydrogen-bond acceptor, Hydrogen-bond donor, Positively charges group (basic), Negatively charged group (acidic), Aromatic ring, Aliphatic hydrophobic moieties, Aromatic hydrophobic moieties, Apical Sodium-dependent Bile acid Transporter or ASBT, NG-OA distance, OA-NG-CG angles, molecular dynamics (MD), Monte Carlo (MC) simulations, CHARMM, AMBER, MMFF, quantum mechanical (QM), replica-exchange MD simulations, Generalized Born Continuum Solvent Model GBMV, Akaike information criteria, SHELL, AIC values, opioid ligands, nonpeptidic opioids, hASBT, DAT/SERT, Accelrys, San Diego, CA, RMSD
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
Molecular Modelling: Principles and Applications
Leach, A. R. (1996) · Cited by 1,945
Journal of Computational and Graphical Statistics
Levine, R. A., Sampson, E., & Lee, T. C. M. (2014) · WIREs Computational Statistics · doi:10.1002/wics.1307 · Cited by 1,424
Generalized Born Models of Macromolecular Solvation Effects
Bashford, D., & Case, D. A. (2000) · Annual Review of Physical Chemistry · doi:10.1146/annurev.physchem.51.1.129 · Cited by 1,146
Theory and applications of the generalized born solvation model in macromolecular simulations
Tsui, V., & Case, D. A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)56:4<275::aid-bip10024>3.0.co;2-e · Cited by 977
Plasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1008 · Cited by 939
Feig, M., Karanicolas, J., & Brooks, C. L. (2004) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2003.12.005 · Cited by 856
Chance factors in studies of quantitative structure-activity relationships
Topliss, J. G., & Edwards, R. P. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00196a017 · Cited by 673
Erythropoietin Receptor Activation by a Ligand-Induced Conformation Change
Remy, I., Wilson, I. A., & Michnick, S. W. (1999) · Science · doi:10.1126/science.283.5404.990 · Cited by 634
Lee, M. S., Feig, M., Salsbury, F. R., & Brooks, C. L. (2003) · Journal of Computational Chemistry · doi:10.1002/jcc.10272 · Cited by 504
IUPAC compendium of chemical terminology
(2003) · Choice Reviews Online · doi:10.5860/choice.40sup-0262 · Cited by 472
Perola, E., & Charifson, P. S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030563w · Cited by 447
Im, W., Feig, M., & Brooks, C. L. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74712-2 · Cited by 385
Multiplexed-Replica Exchange Molecular Dynamics Method for Protein Folding Simulation
Rhee, Y. M., & Pande, V. S. (2003) · Biophysical Journal · doi:10.1016/s0006-3495(03)74897-8 · Cited by 300
Progress in predicting human ADME parameters in silico
Ekins, S., Waller, C. L., Swaan, P. W., Cruciani, G., Wrighton, S. A., & Wikel, J. H. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00109-x · Cited by 274
Robust QSAR Models Using Bayesian Regularized Neural Networks
Burden, F. R., & Winkler, D. A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980697n · Cited by 241
Conformational changes of small molecules binding to proteins
Nicklaus, M. C., Wang, S., Driscoll, J. S., & Milne, G. W. A. (1995) · Bioorganic & Medicinal Chemistry · doi:10.1016/0968-0896(95)00031-b · Cited by 229
Recent advances in structure-based rational drug design
Gane, P. J., & Dean, P. M. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00105-6 · Cited by 192
Apical Sodium Dependent Bile Acid Transporter (ASBT, SLC10A2): A Potential Prodrug Target
Balakrishnan, A., & Polli, J. E. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060022d · Cited by 178
STRUCTURE-BASED DRUG DESIGN:Computational Advances
Marrone, T. J., Briggs, J. M., & McCammon, J. A. (1997) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.71 · Cited by 174
Use of Automatic Relevance Determination in QSAR Studies Using Bayesian Neural Networks
Burden, F. R., Ford, M. G., Whitley, D. C., & Winkler, D. A. (2000) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci000450a · Cited by 134
Increased Acyclovir Oral Bioavailability via a Bile Acid Conjugate
Tolle‐Sander, S., Lentz, K. A., Maeda, D. Y., Coop, A., & Polli, J. E. (2003) · Molecular Pharmaceutics · doi:10.1021/mp034010t · Cited by 120
Self-citationPharmacophore-based discovery of ligands for drug transporters
Chang, C. K., Ekins, S., Bahadduri, P. M., & Swaan, P. W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.006 · Cited by 116
A new search algorithm for QSPR/QSAR theories: Normal boiling points of some organic molecules
Duchowicz, P. R., Castro, E. A., Fernández, F. M., & González, M. P. (2005) · Chemical Physics Letters · doi:10.1016/j.cplett.2005.07.016 · Cited by 110
Comparative Molecular Field Analysis (CoMFA)
Kubinyi, H. (1998) · Wiley eBooks · doi:10.1002/0470845015.cca030 · Cited by 97
Computational Identification of Inhibitors of Protein-Protein Interactions
Zhong, S., Macias, A. T., & MacKerell, A. D. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779318334 · Cited by 87
Analysis of linear and nonlinear QSAR data using neural networks
Manallack, D. T., Ellis, D. D., & Livingstone, D. J. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00048a012 · Cited by 85
Bohl, C. E., Chang, C. K., Mohler, M. L., Chen, J., Miller, D. D., Swaan, P. W., & Dalton, J. T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499007 · Cited by 81
Conformational Sampling and Energetics of Drug-Like Molecules
Foloppe, N., & Chen, I. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709789057680 · Cited by 71
Modelling blood–brain barrier partitioning using Bayesian neural nets
Winkler, D. A., & Burden, F. R. (2004) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2004.03.010 · Cited by 71
Computational approaches to modeling drug transporters
Chang, C. K., & Swaan, P. W. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.09.013 · Cited by 70
An Optimal Self‐Pruning Neural Network and Nonlinear Descriptor Selection in QSAR
Burden, F. R., & Winkler, D. A. (2009) · QSAR & Combinatorial Science · doi:10.1002/qsar.200810202 · Cited by 65
A Consensus Neural Network-Based Technique for Discriminating Soluble and Poorly Soluble Compounds
Manallack, D. T., Tehan, B. G., Gancia, E., Hudson, B. D., Ford, M. G., Livingstone, D. J., Whitley, D. C., & Pitt, W. R. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci0202741 · Cited by 62
Cited by
Molecular Docking and Structure-Based Drug Design Strategies
Ferreira, L., Dos Santos, R., Oliva, G., & Andricopulo, A. (2015) · Molecules · doi:10.3390/molecules200713384 · Cited by 2,528
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
Computational methods in drug discovery
Leelananda, S. P., & Lindert, S. (2016) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.12.267 · Cited by 639
Computer-Aided Drug Design Methods
Yu, W., & MacKerell, A. D. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6634-9_5 · Cited by 583
Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B. (2021) · Medicinal Research Reviews · doi:10.1002/med.21764 · Cited by 429
Metadata
- Authors
- Acharya, C., Coop, A., E. Polli, J., & D. MacKerell, A.
- Venue
- Current Computer Aided-Drug Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2011-03-01
- Volume
- 7
- Issue
- 1
- Pages
- 10-22
- ISSN
- 1573-4099 (ISSN-L)
- OpenAlex
- W2098530568
- Cited by
- 340
- References
- 33
- FWCI
- 4.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.